We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

307 hedge funds and large institutions have $1.65B invested in First Trust NYSE Arca Biotechnology Index Fund in 2026 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 104 increasing their positions, 74 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,148% more call options, than puts

Call options by funds: $4.26M | Put options by funds: $341K

142% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 24

132% more capital invested

Capital invested by funds: $713M → $1.65B (+$942M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

41% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 74

19.07% more ownership

Funds ownership: 53.83%72.9% (+19%)

10% more funds holding

Funds holding: 279307 (+28)

Holders
307
Holders Change
+28
Holders Change %
+10.04%
% of All Funds
3.78%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
58
Increased
104
Reduced
74
Closed
24
Calls
$4.26M
Puts
$341K
Net Calls
+$3.92M
Net Calls Change
+$3.52M
Name Holding Trade Value Shares
Change
Change in
Stake
BDPWM
326
Barnes Dennig Private Wealth Management
Ohio
-$10.3K -50 Closed
PMFA
327
Plante Moran Financial Advisors
Michigan
-$7.64K -37 Closed
FCT
328
First Community Trust
Iowa
-$5.37K -26 Closed
LAS
329
Lloyd Advisory Services
Georgia
-$414 -2 Closed
AT
330
Avenir Tech
Hong Kong
-$207 -1 Closed
LC
331
Luminist Capital
Michigan
-$207 -1 Closed

FBT Hedge Fund Activity: Q1 2026 in Review

307 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2026, worth a combined $1.65B — up 132% from $713M a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new FBT positions and 24 closed out — a net gain of 34 holders — while 104 added to existing stakes and 74 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $726M. The largest seller was Stonebridge Financial Group (Pennsylvania), exiting entirely with an estimated $14.7M sold.

  • 307 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2026, up from 279 in Q4 2025.
  • Funds reported $1.65B of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2026, up 132% quarter-over-quarter.
  • 58 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2026 and 24 closed out, a net change of +34 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2026 was First Trust Advisors, an estimated $726M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2026 was Stonebridge Financial Group (Pennsylvania), an estimated $14.7M sold.

Based on aggregated 13F filings for Q1 2026.